Brentuximab vedotin:APPROVED_TREATMENT(S):Hodgkin lymphoma , Anaplastic large-cell lymphoma####Brentuximab vedotin:TARGET:CD30
All the approved treatments for the target CD30 are hodgkin lymphoma, anaplastic large - cell lymphoma.